Home / Health / Genes Predict Weight-Loss Drug Success
Genes Predict Weight-Loss Drug Success
8 Apr
Summary
- Gene variants influence weight-loss drug effectiveness.
- Specific genes linked to increased weight loss results.
- Genetic factors also correlate with drug side effects.
Genetic variations are now understood to influence the effectiveness of popular weight-loss drugs, offering a pathway to more personalized patient care. A recent study identified a specific variant in the GLP1R gene that is associated with approximately 1.7 pounds of additional weight loss when using medications such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound. This finding suggests that genetic makeup can predict a patient's response to these GLP-1 mimicking drugs.
However, the research also highlights a dual effect, as variations in the GLP1R and GIPR genes were linked to an increased likelihood of experiencing side effects like nausea and vomiting. While genetics are a factor, other conditions such as type 2 diabetes and liver disease also impact treatment efficacy. This growing body of evidence underscores the importance of genetic insights in optimizing obesity treatment strategies and developing better, targeted medications.
